Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift

被引:0
|
作者
Zhang, W. [1 ,2 ]
Zhang, Y. [1 ,2 ]
Ouyang, W. -W. [1 ,2 ]
Su, S. Fa [1 ,2 ]
Ma, Z. [1 ]
Li, Q. -S. [1 ,2 ]
Yang, W. Gang [1 ,2 ]
Chen, X. Xia [1 ,2 ]
Liu, J. [1 ,2 ]
Lu, B. [1 ,2 ]
机构
[1] Guizhou Med Univ, Affiliated Hosp, Affiliated Canc Hosp, Dept Oncol, Guiyang, Peoples R China
[2] Guizhou Med Univ, Dept Oncol, Guiyang, Peoples R China
来源
CANCER RADIOTHERAPIE | 2024年 / 28卷 / 02期
关键词
Postoperative radiotherapy; Non-small cell lung cancer; Quality control; Mediastinal shift; Isocenter point; RESECTION; MOTION;
D O I
10.1016/j.canrad.2023.06.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose.- This study aimed to assess the shifting patterns of the mediastinum, including the target volume and the isocenter point during the postoperative radiotherapy (PORT) process of non-small cell lung cancer (NSCLC), and to observe the occurrence of radiation injury. Additionally, we investigated the significance of mid-term assessment during the implementation of the PORT process. Material and methods.- We established coordinate axes based on bone anatomy and measured the mediastinum's three-dimensional direction and the shift of the isocenter point's shift in the PORT process. Statistical analysis was performed using Wilcoxon, Kruskal-Wallis, and the Chi-square test. P < 0.05 was considered statistically significant. Results.- In this study, the analysis of patients revealed that the shift of anterior and posterior mediastinum (X), left and right mediastinum (Y), upper and lower mediastinum (Z), anterior and posterior isocenter point (X-i), and the left and right isocenter points (Y-i) in the PORT process were 0.04-0.53, 0.00-0.84, 0.00-1.27, 0.01-0.86, and 0.00-0.66 cm, respectively. The shift distance of the mediastinum was Z > Y > X, and the shift distance of the isocenter point was X-i > Y-i. According to the ROC curve, the cut-off values were 0.263, 0.352, 0.405, 0.238, and 0.258, respectively, which were more significant than the cut-off values in 25 cases (25%), 30 cases (30%), 30 cases (30%), 17 cases (17%), and 15 cases (15%). In addition, there was a significant difference in the shift of the mediastinum and the isocenter point (all P = 0.00). Kruskal-Wallis test showed no statistically significant difference between mediastinal shift and resection site in X, Y, and Z directions (P = 0.355, P = 0.239, P = 0.256), surgical method (P = 0.241, P = 0.110, P = 0.064). There was no significant difference in the incidence of RE and RP in PORT patients (P > 0.05). No III-IV RP occurred. However, the incidence of >= grade III RE in the modified plan cases after M-S was significantly lower than in the original PORT patients, 0% and 7%, respectively (P = 0.000). Conclusion.- In conclusion, this study provides evidence that mediastinal shift is a potential complication during the PORT process for patients with N2 stage or R1-2 resection following radical resection of NSCLC. This shift affects about 20-30% of patients, manifesting as actual radiation damage to normal tissue and reducing the local control rate. Therefore, mid-term repositioning of the PORT and revision of the target volume and radiation therapy plan can aid in maintaining QA and QC during the treatment of NSCLC patients and may result in improved patient outcomes. (c) 2023 Published by Elsevier Masson SAS on behalf of Societe francaise de radiotherapie oncologique (SFRO).
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [1] Postoperative radiotherapy in non-small cell lung cancer
    Roelandts, M.
    Moretti, L.
    Van Houtte, P.
    [J]. CANCER RADIOTHERAPIE, 2011, 15 (6-7): : 514 - 517
  • [2] Postoperative radiotherapy for non-small cell lung cancer
    Burdett, Sarah
    Rydzewska, Larysa
    Tierney, Jayne
    Fisher, David
    Parmar, Mahesh K. B.
    Arriagada, Rodrigo
    Pignon, Jean Pierre
    Le Pechoux, Cecile
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10):
  • [3] Postoperative radiotherapy for non-small cell lung cancer
    Stewart, L
    Arriagada, R
    Brichet, AH
    Lafitte, JJ
    Burdett, S
    Girling, DJ
    Parmar, MKB
    Stephens, RJ
    Dautzenberg, B
    Debevec, M
    Kovac, V
    Gregor, A
    Piantadosi, S
    Pignon, J
    Rocmans, P
    Souhami, R
    Torri, V
    Van Houtte, P
    Trodella, L
    Wang, M
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [4] Postoperative radiotherapy for non-small cell lung cancer
    Burdett, Sarah
    Rydzewska, Larysa
    Tierney, Jayne
    Fisher, David
    Parmar, Mahesh K. B.
    Arriagada, Rodrigo
    Pignon, Jean Pierre
    Le Pechoux, Cecile
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (09):
  • [5] Postoperative radiotherapy in localized non-small cell lung cancer
    Rübe, C
    Nguyen, TP
    Fleckenstein, J
    Niewald, M
    [J]. LUNG CANCER, 2001, 33 : S29 - S33
  • [6] Postoperative radiotherapy of non-small cell lung cancer gets ahead!
    Baust, Heinrich
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (05) : 287 - 289
  • [7] Postoperative radiotherapy in radically resected non-small cell lung cancer
    Mayer, R
    SmolleJuettner, FM
    Szolar, D
    Stuecklschweiger, GF
    Quehenberger, F
    Friehs, G
    Hackl, A
    [J]. CHEST, 1997, 112 (04) : 954 - 959
  • [8] Mediastinal Staging in Non-Small Cell Lung Cancer
    Gamliel, Ziv
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 493 - +
  • [9] Role of Postoperative Radiotherapy in Advanced Stage Non-small Cell Lung Cancer
    Kim, M.
    Wu, H.
    Park, C.
    Heo, D.
    Kim, Y.
    Kim, D.
    Lee, S.
    Kim, Y.
    Kim, J.
    Kang, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S460 - S460
  • [10] Mediastinal staging for non-small cell lung cancer
    Leiro-Fernandez, Virginia
    Fernandez-Villar, Alberto
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 496 - 505